All In MedTech

FDA Clearance Tracker · K090626

ENDOSERTER

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 20, 2026Latest source record: Jan 21, 2011 (this decision)Source: openFDAMethods & limitations

510(k)First of its product code

Decided

Jan 21, 2011

Substantially Equivalent

Time to decision

683 days

Received Mar 9, 2009. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Class I

The decision

FDA number
K090626
Device name
ENDOSERTER
Applicant location
Winston-Salem, NC
Received
Mar 9, 2009
Decided
Jan 21, 2011
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class I
Regulation
21 CFR 886.4300
Specialty
Ophthalmology

Every decision under product code OTZ

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code OTZ (Graft Insertion Instrument For Endothelial Keratoplasty).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

  • FDA database record for K090626
  • The applicant filed a statement instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Ocular Systems, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.